CDKN2A and Parkinson disease: This study has comprehensively investigated markers of T cell senescence in a newly diagnosed PD cohort and age-matched controls, and provides evidence of a reduction in CD8+ TEMRA cells, as well as lower expression of the cell-ageing marker p16 in CD8+ T lymphocytes in PD.